Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 21:7:135.
doi: 10.3389/fnut.2020.00135. eCollection 2020.

Caenorhabditis elegans, a Host to Investigate the Probiotic Properties of Beneficial Microorganisms

Affiliations
Review

Caenorhabditis elegans, a Host to Investigate the Probiotic Properties of Beneficial Microorganisms

Cyril Poupet et al. Front Nutr. .

Abstract

Caenorhabditis elegans, a non-parasitic nematode emerges as a relevant and powerful candidate as an in vivo model for microorganisms-microorganisms and microorganisms-host interactions studies. Experiments have demonstrated the probiotic potential of bacteria since they can provide to the worm a longer lifespan, an increased resistance to pathogens and to oxidative or heat stresses. Probiotics are used to prevent or treat microbiota dysbiosis and associated pathologies but the molecular mechanisms underlying their capacities are still unknown. Beyond safety and healthy aspects of probiotics, C. elegans represents a powerful way to design large-scale studies to explore transkingdom interactions and to solve questioning about the molecular aspect of these interactions. Future challenges and opportunities would be to validate C. elegans as an in vivo tool for high-throughput screening of microorganisms for their potential probiotic use on human health and to enlarge the panels of microorganisms studied as well as the human diseases investigated.

Keywords: Caenorhabditis elegans; immunity; lifespan; pathogens; probiotics; stress response.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of bacterial probiotic strains on C. elegans lifespan. (A) Lifespan of C. elegans N2 fed with lactic acid bacteria compared to worms fed with E. coli OP50. The increase in the survival rate is represented for each strain as a percentage of the survival rate of C. elegans fed on E. coli OP50 (, , , , , , –91). (B) Negative effects of L. salivarius and L. reuteri on C. elegans lifespan. The decrease in the survival rate is represented for each strain as a percentage of the survival rate of C. elegans fed on E. coli OP50 (92). The decrease in the survival rate is represented for each strain as a percentage of the survival rate of C. elegans fed on E. coli OP50.
Figure 2
Figure 2
Effects of probiotics L. gasseri SBT2055 (86), L. rhamnosus CNCM I-3690 (11), B. longum (99), and B. subtilis NCIB3610 (114) on C. elegans during abiotic stress. During oxidative stress, the bacteria induce a response in the host via the p38 MAPK and DAF-2/DAF-16 pathways allowing the synthesis of antioxidant metabolites. In the case of thermal stress, a neural response induces the synthesis of heat-shock proteins to allow thermotolerance. In both cases, the result is an increase in the longevity of the host.
Figure 3
Figure 3
Molecular interactions and signaling pathways involved in C. elegans immune response. In the nematode, three highly conserved signaling pathways are the basis of the immune response protecting the animal from biological and abiotic aggression. These pathways are the p38 MAPK, the DAF-2/Insulin-like receptor and the JNK pathways. Interconnections and back-controls exist in these signal cascades and allow for fine control of the defense mechanisms put in place in the face of aggression. Transcriptomic analyses have revealed the absence of overlapping in the expression of genes regulated by these pathways.
Figure 4
Figure 4
(A) Strategy and workflow for screening, selecting, and studying probiotic microorganisms using an integrated process. A collection of microorganisms of interest must be tested by conventional in vitro methods to select strains that meet the eligibility criteria defined in the literature. These candidates are then characterized using the C. elegans model to describe their physiological and molecular characteristics to move on to the next steps. These consist of the establishment of preclinical models (i.e., rodents) and then clinical trials in humans before a possible marketing as a drug (or any other galenic form). (B) Manual C. elegans analysis workflow representing the numerous steps required by manual experiments. (C) Full automated C. elegans analysis workflow allowing a reduction in the number of steps, a reduction in the time required for the experimenter as well as biases inherent in handling errors.

References

    1. FAO/WHO Evaluation of health and nutritional properties of probiotics in food including powder milk with live acid bacteria. Report of a Joint FAO/WHO Expert Consultation, Córdoba, Argentina (2001). Available online at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.p...
    1. Olle B. Medicines from microbiota. Nat Biotechnol. (2013) 31:309–15. 10.1038/nbt.2548 - DOI - PubMed
    1. Desreumaux P, Pavan S, Mercenier A. Probiotiques, prébiotiques et symbiotiques. La Lett Hépato Gastroentérol. (2000) 3:335–7.
    1. Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 10(Suppl. 1):S49–66. 10.1093/advances/nmy063 - DOI - PMC - PubMed
    1. Shokryazdan P, Jahromi MF, Liang JB, Ramasamy K, Sieo CC, Ho YW. Effects of a Lactobacillus salivarius mixture on performance, intestinal health and serum lipids of broiler chickens. PLoS ONE. (2017) 12:e0175959. 10.1371/journal.pone.0175959 - DOI - PMC - PubMed

LinkOut - more resources